• MM MM

    Multiple Myeloma Home

    REVLIMID® (lenalidomide)

    Product Information Resources PBS

    POMALYST® (pomalidomide)

    Product Information Resources PBS

    THALOMID® (thalidomide)

    Product Information Resources

    EMPLICITI® (elotuzumab)

    Product Information Resources PBS
  • AML
  • PBS
    Information
    REVLIMID® (lenalidomide) POMALYST® (pomalidomide) EMPLICITI® (elotuzumab) ONUREG® (azacitidine)
  • Resources

  • Product
    Information

    REVLIMID® (lenalidomide) POMALYST® (pomalidomide) THALOMID® (thalidomide) EMPLICITI® (elotuzumab) ONUREG® (azacitidine)

Failed

 
Celgene │ Bristol Myers SquibbTM Company
Contact Us Legal Notice i-access® Program Privacy Policy Modern Slavery Statement © 2025 Bristol-Myers Squibb

REVLIMID®, POMALYST®, THALOMID®, ONUREG® and EMPLICITI® are registered trademarks of Bristol Myers Squibb Company.
Level 2, 4 Nexus Court, Mulgrave VIC 3170.

466-AU-2500003.
Date of preparation: May 2025.

  • 5 languages available

    Arabic Chinese English Italian Greek Vietnamese

  • 5 languages available

    Arabic Chinese English Italian Greek Vietnamese